NME1 and cancer: Previous studies have found that elevated expression of NM23 protein was associated with the decreased metastatic capacity of many malignant tumors.[6,65] The reduced NM23 protein expression contributes substantially to the metastatic process, indicating that metastatic tumor cells are mainly composed of cells with low NM23 expression.